| Jun 28 |
Gain Therapeutics to Hold a Business Update Conference Call on July 1, 2024
|
| Jun 27 |
Gain Therapeutics names Gene Mack as Interim CEO
|
| Jun 27 |
Gain Therapeutics, Inc. Appoints Gene Mack as Interim CEO
|
| Jun 27 |
Gain Therapeutics Presents GT-02287 Data at Federation of European Neuroscience Societies (FENS) Forum 2024 Demonstrating Improvements in Cognitive Performance in a Preclinical Model of GBA1 Parkinson’s disease
|
| Jun 25 |
Gain Therapeutics to Participate at H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
|
| Jun 14 |
Dow Tumbles Over 200 Points; Adobe Earnings Top Views
|
| Jun 14 |
Gain Therapeutics shares slide on pricing public offering of units to raise $11M
|
| Jun 14 |
Gain Therapeutics Announces Pricing of $11.0 Million Public Offering
|
| Jun 13 |
Gain Therapeutics shares fall on proposed public offering
|
| Jun 13 |
Gain Therapeutics Announces Proposed Public Offering
|
